These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2541093)

  • 21. High dosage anticholinergic therapy in dystonia.
    Fahn S
    Neurology; 1983 Oct; 33(10):1255-61. PubMed ID: 6136938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia.
    Arana GW; Goff DC; Baldessarini RJ; Keepers GA
    Am J Psychiatry; 1988 Aug; 145(8):993-6. PubMed ID: 2899403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholine and affective disorder.
    Leong SS; Brown WA
    J Neural Transm; 1987; 70(3-4):295-312. PubMed ID: 3316493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The problems of anticholinergic adverse effects in older patients.
    Feinberg M
    Drugs Aging; 1993; 3(4):335-48. PubMed ID: 8369593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dystonia, neuroleptic dose, and anticholinergic drugs.
    McEvoy JP; Simpson GM
    Am J Psychiatry; 1987 Mar; 144(3):393-4. PubMed ID: 2881496
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
    Dubois B; Pilon B; Lhermitte F; Agid Y
    Ann Neurol; 1990 Aug; 28(2):117-21. PubMed ID: 2221841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history and treatment of tardive dystonia.
    Kang UJ; Burke RE; Fahn S
    Mov Disord; 1986; 1(3):193-208. PubMed ID: 2904118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of body turn-brightness associations in the effect of scopolamine on response-to-change in the rat.
    Lukaszewska I; Dławichowska E
    Acta Neurobiol Exp (Wars); 1989; 49(6):381-6. PubMed ID: 2638548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimuscarinic drugs in the treatment of movement disorders.
    Fahn S; Burke R; Stern Y
    Prog Brain Res; 1990; 84():389-97. PubMed ID: 2267310
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute laryngeal dystonic reactions to neuroleptics.
    Koek RJ; Pi EH
    Psychosomatics; 1989; 30(4):359-64. PubMed ID: 2572029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed-onset dystonia due to perinatal or early childhood asphyxia.
    Saint Hilaire MH; Burke RE; Bressman SB; Brin MF; Fahn S
    Neurology; 1991 Feb; 41(2 ( Pt 1)):216-22. PubMed ID: 1992364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dystonia].
    Nakamura S; Mimori Y
    Nihon Rinsho; 1993 Nov; 51(11):2835-41. PubMed ID: 8277558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained-release anticholinergics in dystonia: case report.
    Samie MR
    Neurology; 1987 May; 37(5):885-6. PubMed ID: 3574699
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of locally infused pharmacological agents on spontaneous and sensory-evoked activity of locus coeruleus neurons.
    Adams LM; Foote SL
    Brain Res Bull; 1988 Sep; 21(3):395-400. PubMed ID: 2850842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dystonia.
    Chiu H
    Br J Psychiatry; 1989 Nov; 155():715-6. PubMed ID: 2575426
    [No Abstract]   [Full Text] [Related]  

  • 36. Hippocampal cholinergic blockade enhances hypothalamic-pituitary-adrenal responses to stress.
    Bhatnagar S; Costall B; Smythe JW
    Brain Res; 1997 Aug; 766(1-2):244-8. PubMed ID: 9359609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.
    Valencak J; Raderer M; Kornek GV; Henja MH; Scheithauer W
    J Natl Cancer Inst; 1998 Jan; 90(2):160. PubMed ID: 9450578
    [No Abstract]   [Full Text] [Related]  

  • 38. Grooming behavior induced by ACTH involves cerebral cholinergic neurons and muscarinic receptors.
    Dunn AJ; Vigle G
    Neuropharmacology; 1985 Apr; 24(4):329-31. PubMed ID: 2987726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Adv Neurol; 1988; 50():193-201. PubMed ID: 2456675
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between cholinergic airway tone and serum immunoglobulin E in human subjects.
    Endoh N; Ichinose M; Takahashi T; Miura M; Kageyama N; Mashito Y; Sugiura H; Ikeda K; Takasaka T; Shirato K
    Eur Respir J; 1998 Jul; 12(1):71-4. PubMed ID: 9701417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.